ArticleScientific reports2026
Turn-on quinoline probe for selective sensing of hypochlorite in live cells.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hypochlorite is a highly reactive oxygen species (ROS) implicated in diverse physiological and pathological processes. Elevated hypochlorite levels cause oxidative stress, leading to structural and functional disruptions in biomacromolecules and contributing to the onset and progression of disease. Despite significant progress, many reported hypochlorite probes suffer from relatively high molecular weights and often depend on emission shifts, which complicate sensitivity and quantitative analysis. To overcome these limitations, we developed a low-molecular-weight quinoline-derived probe 5 that, to our knowledge, represents the first example of a quinoline-phenothiazine-based hypochlorite sensor that is non-fluorescent in its basal state yet undergoes a selective oxidative transformation to yield a robust emission at 523 nm. The probe exhibits exceptional temporal resolution, with fluorescence activation observed within 10 s in cell-free assays and generates a visible signal that scales directly with ROS concentration. Importantly, the probe maintains performance in live-cell studies, where activation occurs in a concentration-dependent manner. Altogether, these results establish 5 as a rapid, sensitive, and biologically compatible tool for monitoring hypochlorite dynamics in real time, advancing the design of next-generation ROS probes by combining low molecular weight, rapid response time, and straightforward readout.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.